Aclarion Adds Texas Back Institute to CLARITY Trial for Chronic Low Back Pain

Aclarion Inc. (Nasdaq: ACON, ACONW) has reported that the Texas Back Institute (TBI) will serve as a new site for the CLARITY (C hronic L ow b A ck pain R andomized I ndependent T rial stud Y) clinical trial. TBI is widely recognized for its contributions to spine technology, education and patient care. The…

This Article Is Locked, But Not Out of Reach

Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.

Create My Free Account

Curious how it works? Watch the Quickstart

Want everything unlocked? See Paid Options

Already a member? Log in here